BioSig Technologies Files 8-K for Material Agreement
Ticker: STEX · Form: 8-K · Filed: Sep 8, 2025 · CIK: 1530766
| Field | Detail |
|---|---|
| Company | Biosig Technologies, Inc. (STEX) |
| Form Type | 8-K |
| Filed Date | Sep 8, 2025 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, disclosure
TL;DR
BioSig filed an 8-K on 9/8/25 for a material agreement.
AI Summary
BioSig Technologies, Inc. filed an 8-K on September 8, 2025, reporting on a material definitive agreement. The filing indicates the company is based in Delaware and its principal executive offices are located at 12424 Wilshire Blvd., Ste 745, Los Angeles, California.
Why It Matters
This filing signals a significant development in BioSig Technologies' business operations, potentially impacting its strategic direction and financial performance.
Risk Assessment
Risk Level: low — The filing is a standard disclosure of a material agreement and does not inherently present new risks.
Key Numbers
- 001-38659 — SEC File Number (Identifier for the company's filings)
- 26-4333375 — IRS Employer Identification No. (Tax identification for the company)
Key Players & Entities
- BioSig Technologies, Inc. (company) — Registrant
- September 8, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 12424 Wilshire Blvd., Ste 745 Los Angeles, California 90025 (address) — Address of principal executive offices
FAQ
What is the nature of the material definitive agreement?
The filing does not specify the details of the material definitive agreement, only that one has been entered into.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on September 8, 2025.
Where are BioSig Technologies, Inc.'s principal executive offices located?
The principal executive offices are located at 12424 Wilshire Blvd., Ste 745, Los Angeles, California 90025.
In which state was BioSig Technologies, Inc. incorporated?
BioSig Technologies, Inc. was incorporated in Delaware.
What is the SIC code for BioSig Technologies, Inc.?
The Standard Industrial Classification (SIC) code is 3845 for ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS.
Filing Stats: 919 words · 4 min read · ~3 pages · Grade level 12.1 · Accepted 2025-09-08 15:59:06
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share BSGM The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 43KB
- ex10-1.htm (EX-10.1) — 177KB
- ex99-1.htm (EX-99.1) — 27KB
- ex99-1_001.jpg (GRAPHIC) — 4KB
- ex99-1_002.jpg (GRAPHIC) — 3KB
- 0001641172-25-026853.txt ( ) — 456KB
- bsgm-20250908.xsd (EX-101.SCH) — 3KB
- bsgm-20250908_lab.xml (EX-101.LAB) — 33KB
- bsgm-20250908_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 10.1 Tokenized Yield Partnership Agreement, dated as of September 8, 2025, between BioSig Technologies, Inc. and Monetary Metals & Co. 99.1 Press Release, dated September 8, 2025 104 Cover Page Interactive Data File (formatted as Inline XBRL)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BIOSIG TECHNOLOGIES, INC. Date: September 8, 2025 By: /s/ Karl Henry McPhie Name: Karl Henry McPhie Title: Chief Executive Officer